Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events

伏立康唑 医学 内科学 曲菌病 回顾性队列研究 治疗药物监测 不利影响 造血干细胞移植 入射(几何) 移植 胃肠病学 免疫学 药代动力学 皮肤病科 物理 抗真菌 光学
作者
Helen Y. Chu,Rupali Jain,Hu Xie,Paul S. Pottinger,David N. Fredricks
出处
期刊:BMC Infectious Diseases [BioMed Central]
卷期号:13 (1): 105-105 被引量:74
标识
DOI:10.1186/1471-2334-13-105
摘要

BACKGROUND: Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. METHODS: We performed a retrospective cohort study of patients at the University of Washington Medical Center and Fred Hutchinson Cancer Research Center from 2007-2009. We compared the effect of therapeutic levels on clinical outcomes and evaluated the relationship between drug levels and adverse events. RESULTS: A total of 108 patients had voriconazole TDM performed, of whom 84 (77.8%) had a hematologic malignancy and 47 (43.5%) had undergone hematopoietic stem cell transplantation. The primary reasons for treatment were presumed pulmonary aspergillosis (n = 83, 76.8%), other invasive mould infections (n = 13, 12.0%) and candidiasis (n = 9, 8.3%). There was a high degree of variability in voriconazole drug levels among patients (r2 = 0.01; range, <0.10 - 20 mg/L). Of the 46 patients with proven or probable invasive fungal disease, 25 (54.3%) achieved partial or complete response to therapy. There was no significant relationship between therapeutic drug levels and achievement of complete or partial response at 12 weeks (OR 0.29, 95% CI: 0.05-1.34) or radiologic response (OR 1.46, 95% CI: 0.32-7.83). Overall, 45 (41.7%) patients experienced adverse events. Voriconazole levels > 5.5 mg/L were not associated with increased incidence of encephalopathy (OR 3.08, 95% CI 0.79-11.0) or hepatotoxicity (OR 2.45, 95% CI 0.49-10.1). CONCLUSIONS: Voriconazole therapeutic drug levels were not associated with improvement in clinical outcomes among patients with proven or probable invasive fungal disease. We also did not find an association between supratherapeutic drug levels and hepatoxicity or encephalopathy. It is possible that the utility of voriconazole therapeutic drug monitoring to improve clinical efficacy or decrease adverse events may be limited to a subset of high-risk patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Katrina完成签到,获得积分10
刚刚
传奇3的应助被干净夏天采纳,获得10
刚刚
黎建东发布了新的文献求助10
刚刚
刚刚
自觉的海之完成签到 ,获得积分10
1秒前
车厘子完成签到 ,获得积分10
1秒前
2秒前
xasz完成签到,获得积分10
2秒前
2秒前
xx发布了新的文献求助10
2秒前
2秒前
修染完成签到 ,获得积分10
3秒前
天天快乐的应助被youyou采纳,获得10
3秒前
luxiaodan完成签到,获得积分10
3秒前
荼蘼发布了新的文献求助30
3秒前
感动雁芙完成签到,获得积分20
3秒前
csz完成签到,获得积分10
3秒前
自由的舞蹈完成签到,获得积分10
3秒前
flappy完成签到,获得积分10
4秒前
5秒前
Anonymous的应助被李薇采纳,获得20
5秒前
陌生人儁完成签到,获得积分10
5秒前
5秒前
5秒前
Lemon完成签到 ,获得积分10
5秒前
风吹麦浪的应助被stlibhgq采纳,获得10
6秒前
无辜百合完成签到,获得积分10
6秒前
YYY完成签到,获得积分10
6秒前
瘦瘦毛豆完成签到,获得积分10
6秒前
村口的帅老头完成签到 ,获得积分0
6秒前
Lucas的应助被Pan采纳,获得10
6秒前
希望天下0贩的0的应助被王达采纳,获得10
6秒前
令嘉发布了新的文献求助10
7秒前
ML发布了新的文献求助10
7秒前
7秒前
shilimiao发布了新的文献求助10
7秒前
Maestro_S的应助被超级的鹅采纳,获得10
7秒前
hyx完成签到,获得积分20
7秒前
yang完成签到,获得积分10
8秒前
Rommel完成签到,获得积分20
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180807
求助须知:如何正确求助?哪些是违规求助? 9570895
关于积分的说明 21815089
捐赠科研通 7777155
什么是DOI,文献DOI怎么找? 3433347
关于科研通互助平台的介绍 2557613
邀请新用户注册赠送积分活动 2479317